Antiplatelet therapy and anticoagulation in patients with hypertension

American Family Physician

Volumn 71, Issue 5, 2005, Pages 897-899

  Griffin, Glenn ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IIB; PLACEBO; TICLOPIDINE;

ANTICOAGULANT THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REGIMEN; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; HYPERTENSION; LOW DRUG DOSE; MEDITERRANEAN DIET; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SMOKING CESSATION; STROKE; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

ANTICOAGULANTS; ASPIRIN; CLINICAL TRIALS; HUMANS; HYPERTENSION; PLATELET AGGREGATION INHIBITORS;

EID: 14644408752     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Lip GY, Felmeden DC. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database Syst Rev 2004;(4):CD003186.
2. Langman MJ. Ulcer complications associated with antiinflammatory drug use. What is the extent of the disease burden? Pharmacoepidemiol Drug Saf 2001;10:13-9.
3. Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration [published correction appears in BMJ 1994;308:1540]. BMJ 1994;308:81-106.
4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004;329:15-9.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
6. Sudlow C, Lonn E, Pignone M, Ness A, Rihal C. Secondary prevention of ischaemic cardiac events. Clin Evid 2002:129-68.